**Author details**

Şule Gökçe Faculty of Medicine, Department of Pediatrics, Ege Üniversity, Izmir, Turkey

\*Address all correspondence to: sule.gokce@ege.edu.tr

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**37**

*One of the Main Problems of Infants: Bronchiolitis DOI: http://dx.doi.org/10.5772/intechopen.89417*

population-based birth cohort study.

PLoS One. 2014;**9**:89186

2003;**289**:179-186

[10] Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. Journal of the American Medical Association.

[11] The Impact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics. 1998;**102**:531-537

[12] Alansari K, Toaimah FH, Almatar DH, El Tatawy LA,

Pediatrics. 2019;**143**:1-7

Davidson BL, Qusad MIM. Monoclonal antibody treatment of RSV bronchiolitis in young infants: A randomized trial.

[13] Center for Disease Prevention and Control. Acute bronchiolitis-associated outpatient visits and hospitalizations among American Indian and Alaska native children—United States, 1990- 2000. MMWR. Morbidity and Mortality

Weekly Report. 2003;**52**:707-710

[14] Miller EK, Gebretsadik T, Carroll KN, et al. Viral etiologies of infant bronchiolitis, croup and upper respiratory illness during 4 consecutive years. The Pediatric Infectious Disease

Journal. 2013;**32**:950-955

2010;**11**:39-45

[15] Wainwright C. Acute viral bronchiolitis in children—A very common condition with few therapeutic options. Paediatric Respiratory Reviews.

[16] Resch B, Kurath-Koller S,

Pediatrics. 2016;**12**:8-18

Eibisberger M, Zenz W. Prematurity and the burden of influenza and respiratory syncytial virus disease. World Journal of

[2] Boyce TG, Mellen BG, Mitchel EF Jr, Wright PF, Griffin MR. Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid. The Journal of Pediatrics.

[3] American Academy of Pediatrics Subcommittee on Diagnosis and

[4] Smyth RL, Openshaw PJ.

Immunology. 2008;**8**:150-153

[6] Lanari M, Prinelli F, Adorni F, et al. Risk factors for bronchiolitis hospitalization during the first year of life in a multicenter Italian birth cohort. Italian Journal of

Pediatrics. 2015;**41**:40

2006;**118**:2418-2423

2015;**350**:h2305

[7] Pelletier AJ, Mansbach JM, Camargo CA Jr. Direct medical costs of bronchiolitis hospitalizations in the United States. Pediatrics.

[8] Ricci V, Delgado Nunes V,

Murphy MS, Cunningham S, Guideline Development Group and Technical Team. Bronchiolitis in children: Summary of NICE guidance. BMJ.

[9] Murray J, Bottle A, Sharland M, et al. Risk factors for hospital admission with RSV bronchiolitis in England: A

Management of Bronchiolitis. Diagnosis and management of bronchiolitis. Pediatrics. 2006;**118**:1774-1793

Bronchiolitis. Lancet. 2006;**368**:312-322

[5] Walton RP, Johnston SL. Role of respiratory viral infections in the development of atopic conditions. Current Opinion in Allergy and Clinical

**References**

2000;**137**:865-870

[1] Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA. 1999;**282**:1440-1446 *One of the Main Problems of Infants: Bronchiolitis DOI: http://dx.doi.org/10.5772/intechopen.89417*
